Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Crigler-Najjar Syndrome Type I”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Testing effectiveness (Phase 2)Looking for participantsNCT06641154
What this trial is testing

Gene Therapy for Crigler Najjar Syndrome Type I (AlphaCN)

Who this might be right for
Crigler-Najjar Syndrome Type I
Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare 5
Not applicableStudy completedNCT03078881
What this trial is testing

Clinical Assessment Study in Crigler-Najjar Syndrome

Who this might be right for
Crigler-Najjar Syndrome
Audentes Therapeutics 8
Not applicableEnded earlyNCT03343756
What this trial is testing

HepaStem Long-Term Safety Registry

Who this might be right for
Urea Cycle DisorderCrigler-Najjar SyndromeAcute on Chronic Liver Failure
Cellaion SA 44
Not applicableUnknownNCT02356978
What this trial is testing

New Phototherapy Device to Treat Patients With Crigler-Najjar Disease

Who this might be right for
Crigler Najjar SyndromeChildren
Assistance Publique - Hôpitaux de Paris 6
Not applicableStudy completedNCT02051049
What this trial is testing

Long-term Safety Follow-up Study of Patients Having Received HepaStem (SAF001)

Who this might be right for
Urea Cycle DisordersCrigler Najjar Syndrome
Cellaion SA 9
Testing effectiveness (Phase 2)Looking for participantsNCT06518005
What this trial is testing

Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome

Who this might be right for
Crigler-Najjar Syndrome
Genethon 3
Early research (Phase 1)Ended earlyNCT01345578
What this trial is testing

Hepatocyte Transplantation for Liver Based Metabolic Disorders

Who this might be right for
Metabolic Diseases
Ira Fox 5
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Not applicableLooking for participantsNCT03466463
What this trial is testing

Gene Therapy for Severe Crigler Najjar Syndrome

Who this might be right for
Crigler-Najjar Syndrome
Genethon 17
Testing effectiveness (Phase 2)Study completedNCT01765283
What this trial is testing

Safety Study of HepaStem for the Treatment of Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN)

Who this might be right for
Urea Cycle DisordersCrigler Najjar Syndrome
Cellaion SA 20
Early research (Phase 1)Ended earlyNCT03223194
What this trial is testing

Gene Transfer Clinical Study in Crigler-Najjar Syndrome

Who this might be right for
Crigler-Najjar Syndrome
Audentes Therapeutics 1
Not applicableStudy completedNCT00461799
What this trial is testing

Orlistat Treatment of Crigler-Najjar Disease

Who this might be right for
Crigler-Najjar Syndrome
University Medical Center Groningen 16
Not applicableStudy completedNCT02302690
What this trial is testing

Immunity Against AAV in Crigler Najjar Patient

Who this might be right for
Crigler Najjar Syndrome
Genethon 49